A study of omalizumab in patients with severe asthma.
Latest Information Update: 12 Jul 2017
Price :
$35 *
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 12 Jul 2017 New trial record
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society